Methods of Medical Treatment: Still Not an “Invention” in Canada – IP
By Vincent M. de Grandpré, Martin Brandsma On January 27, 2014, the Federal Court of Appeal in Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co., 2014 FCA 17 (Novartis), upheld the Federal Court’s denial of an application for a prohibition order under the CanadianPatented Medicines (Notice of Compliance) Regulations on the basis that the impugned patent was directed to […]